All In MedTech

Device Trial Radar · NCT02169401

A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment for Chronic Pain

a PRospEctive Post Market Trial of Drg stImulation With the Commercially Available Axium

Last checked: Nov 20, 2026Latest source record: Nov 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

135

Actual

Start

Nov 2012

Primary completion

Jan 25, 2017

Study completion Jan 25, 2017

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jun 23, 2014

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

08-SMI-2012 is a post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of intractable, chronic pain.

Conditions

  • Chronic Pain

Interventions

  • Implantation with the commercially available Axium NeurostimulatorDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain Relief- Change in VAS Pain Intensity From Baseline to Post ImplantationTime frame: Post implantation at; 1, 3, 6, 12 and 24 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • James Cook University Hospital

    Middlesbrough, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.